1,022
Views
0
CrossRef citations to date
0
Altmetric
Pharmacology & Pharmaceutics

Investigation of effects of traditional Chinese medicine astragalus heart-protecting decoction on rats with dilated cardiomyopathy

, , , , , & show all
Pages 846-854 | Received 19 Jan 2021, Accepted 22 Jul 2021, Published online: 14 Sep 2021

References

  • Bai H, Li Y, Han K, Gong M, Ma A. 2013. Effectiveness of Chinese herbal medicine as an adjunctive treatment for dilated cardiomyopathy in patients with heart failure. J Altern Complement Med. 19(10):811–819.
  • Chaves AT, Menezes CA, Costa HS, Nunes MC, Rocha MO. 2019. Myocardial fibrosis in chagas disease and molecules related to fibrosis. Parasite Immunol. 41(10):e12663.
  • Chin KM, Rubin LJ, Channick R, Di Scala L, Gaine S, Galiè N, Ghofrani H-A, Hoeper MM, Lang IM, McLaughlin VV. 2019. Association of N-terminal Pro brain natriuretic peptide and long-term Outcome in patients With pulmonary arterial hypertension: insights from the phase III GRIPHON study. Circulation. 139(21):2440–2450.
  • Gao K, Song Y-P, Song A, Chen H, Zhao L-T, Zhang H-W. 2020. Therapeutic efficacy of shenmai injection as an adjuvant treatment in dilated cardiomyopathy: A protocol for systematic review. Medicine (Baltimore). 99(8):e19158.
  • Hu Y, Wang J. 2019. Interactions between clopidogrel and traditional Chinese medicine. J Thromb Thrombolysis. 48(3):491–499.
  • Jammal Addin MB, Young D, McCarrison S, Hunter L. 2019. Dilated cardiomyopathy in a national paediatric population. Eur J Pediatr. 178(8):1229–1235.
  • Li J, Wu S, Tang HT, Zhu GW. 2016. [Effects of electroacupuncture at neiguan (PC6) on protein expressions of Raf-1, ERK 1/2, and p-ERK 1/2 of rats with myocardial hypertrophy]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 36(11):1335–1339.
  • Liang H, Müller J, Weng Y-G, Wallukat G, Fu P, Lin H-S, Bartel S, Knosalla C, Pregla R, Hetzer R. 2004. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy. Chin Med J. 117(3):401–407.
  • Lin XF, Luo JW, Liu G, Zhu YB, Jin Z, Lin X. 2018. Genetic mutation of familial dilated cardiomyopathy based on next-generation semiconductor sequencing. Mol Med Rep. 18(5):4271–4280.
  • Liu Q, Su X-J, Yu Y, Liu Y-L. 2014. Correlations among persistent viral infection, heart function and Chinese medicine syndromes in dilated cardiomyopathy patients. Chin J Integr Med. 20(12):928–933.
  • Ma Y, Chen M, Guo Y, Liu J, Chen W, Guan M, Wang Y, Zhao X, Wang X, Li H. 2019. Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary. APMIS. 127(5):372–384.
  • Martens P, Nuyens D, Rivero-Ayerza M, Van Herendael H, Vercammen J, Ceyssens W, Luwel E, Dupont M, Mullens W. 2019. Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction. Clin Res Cardiol. 108(10):1074–1082.
  • Mirastschijski U, Dinesh N, Baskaran S, Wedekind D, Gavrilovic J, Murray MY, Bevan D, Kelm S. 2019. Novel specific human and mouse stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) antibodies for biochemical and immunohistochemical analyses. Wound Repair Regen. 27(4):309–323.
  • Omori T, Nakamori S, Fujimoto N, Ishida M, Kitagawa K, Ichikawa Y, Kumagai N, Kurita T, Imanaka-Yoshida K, Hiroe M, Sakuma H. 2020. Myocardial native T(1) predicts load-independent left ventricular chamber stiffness In patients With HFpEF. JACC Cardiovasc Imaging. 13(10):2117–2128.
  • Phacharapiyangkul N, Wu L, Lee W, Kuo Y, Wu Y, Liou H, Tsai Y, Lee C. 2019. The extracts of astragalus membranaceus enhance chemosensitivity and reduce tumor indoleamine 2, 3-dioxygenase expression. Int J Med Sci. 16(8):1107–1115.
  • Reichart D, Magnussen C, Zeller T, Blankenberg S. 2019. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature. J Intern Med. 286(4):362–372.
  • Sanz R, Mazzei L, Manucha W. 2019. Implications of the transcription factor WT1 linked to the pathologic cardiac remodeling post-myocardial infarction. Clin Investig Arterioscler. 31(3):121–127.
  • Schelbert EB. 2019. Myocardial scar and fibrosis: The ultimate mediator of outcomes? Heart Fail Clin. 15(2):179–189.
  • Schultheiss HP, Fairweather D, Caforio AL, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Priori SG. 2019. Dilated cardiomyopathy. Nat Rev Dis Primers. 5(1):32–32.
  • Shan H, Zheng X, Li M. 2019. The Effects of astragalus membranaceus active extracts on autophagy-related diseases. Int J Mol Sci. 20(8):1904.
  • Shen L-J, Lu S, Zhou Y-H, Li L, Xing Q-M, Xu Y-L. 2016. Developing a rat model of dilated cardiomyopathy with improved survival. J Zhejiang Univ Sci B. 17(12):975–983.
  • Sun R, Wang J, Zheng Y, Li X, Xie T, Li R, Liu M, Cao Y, Lu L, Zhang Q. 2017. Traditional Chinese medicine baoxin decoction improves cardiac fibrosis of rats with dilated cardiomyopathy. Exp Ther Med. 13(5):1900–1906.
  • Treibel TA, Badiani S, Lloyd G, Moon JC. 2019. Multimodality Imaging markers of adverse myocardial remodeling in aortic stenosis. JACC Cardiovasc Imaging. 12(8):1532–1548.
  • Wang C, Du H, Hou J, Yan S, Yang J, Wang Y, Zhang X, Zhu L, Zhao H. 2018. Chaihulonggumulitang shows psycho-cardiology Therapeutic Effects on acute myocardial infarction by enhancing bone marrow mesenchymal stem cells mobilization. Sci Rep. 8(1):3724–3724.
  • Wei W, Peng J, Li J. 2019. Curcumin attenuates hypoxia/reoxygenation-induced myocardial injury. Mol Med Rep. 20(6):4821–4830.
  • Xu L, Xu X-Y, Hou X-Q, Wang F-G, Gao S, Zhang H-T. 2020. Adjuvant therapy with astragalus membranaceus for post-stroke fatigue: a systematic review. Metab Brain Dis. 35(1):83–93.
  • You M, Lin M, Gong Y, Wang S, Li A, Ji L, Zhao H, Ling K, Wen T, Huang Y, Gao D. 2017. Household fluorescent lateral flow strip platform for sensitive and quantitative prognosis of heart failure using dual-Color upconversion nanoparticles. ACS Nano. 11(6):6261–6270.
  • Yu J, Zeng C, Wang Y. 2019. Epigenetics in dilated cardiomyopathy. Curr Opin Cardiol. 34(3):260–269.
  • Zhang YY, Yi M, Huang YP. 2017. Oxymatrine ameliorates doxorubicin-induced cardiotoxicity in rats. Cell Physiol Biochem. 43(2):626–635.